Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

10.21
Delayed Data
As of Mar 27
 -0.09 / -0.87%
Today’s Change
4.07
Today|||52-Week Range
12.88
+8.73%
Year-to-Date

Today’s Trading

Previous close10.30
Today’s open10.34
Day’s range10.12 - 10.58
Volume427,313
Average volume (3 months)619,595
Market cap$391.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)+30.11%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.11+1.20%
SPPISpectrum Pharmaceuti...+0.05+0.92%
PGNXProgenics Pharmaceut...+0.08+1.40%
IDRAIdera Pharmaceutical...-0.07-1.86%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 18, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account